🇺🇸 FDA
Pipeline program

Tetravalent Dengue Vaccine (TDV)

DEN-307

Phase 3 mab active

Quick answer

Tetravalent Dengue Vaccine (TDV) for Dengue Fever is a Phase 3 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Dengue Fever
Phase
Phase 3
Modality
mab
Status
active

Clinical trials